These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 29959725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP, Tutuian R, Zerbib F, Rogers BD, Frazzoni M, Roman S, Savarino E, de Bortoli N, Vela MF, Sifrim D.
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [Abstract] [Full Text] [Related]

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G.
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [Abstract] [Full Text] [Related]

  • 4. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
    Frazzoni L, Frazzoni M, de Bortoli N, Tolone S, Furnari M, Martinucci I, Bertani H, Marchi S, Conigliaro R, Fuccio L, Savarino V, Savarino E.
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
    [Abstract] [Full Text] [Related]

  • 5. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S.
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [Abstract] [Full Text] [Related]

  • 6. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo® wireless esophageal pH monitoring study.
    Schey R, Alla SP, Midani D, Parkman HP.
    Rev Gastroenterol Mex; 2017 Jan; 82(4):277-286. PubMed ID: 28385467
    [Abstract] [Full Text] [Related]

  • 7. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
    Triadafilopoulos G, Kamal A, Clarke JO.
    Dis Esophagus; 2023 Jul 03; 36(7):. PubMed ID: 36567531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK, Marcus SN, Triadafilopoulos G.
    Dig Dis Sci; 2011 Oct 03; 56(10):2871-8. PubMed ID: 21512760
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
    Shetler KP, Bikhtii S, Triadafilopoulos G.
    Dis Esophagus; 2017 Jun 01; 30(6):1-8. PubMed ID: 28475749
    [Abstract] [Full Text] [Related]

  • 15. Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy.
    Mandaliya R, DiMarino AJ, Cohen S.
    Dis Esophagus; 2016 Jan 01; 29(1):27-33. PubMed ID: 25294046
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease.
    Yoshimine T, Funaki Y, Kawamura Y, Tamura Y, Izawa S, Ebi M, Ogasawara N, Murotani K, Sasaki M, Kasugai K.
    Digestion; 2019 Jan 01; 99(2):157-165. PubMed ID: 30179879
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.
    Januszewicz W, Hartley J, Waldock W, Roberts G, Alias B, Hobson A, Wernisch L, di Pietro M.
    United European Gastroenterol J; 2019 Dec 01; 7(10):1389-1398. PubMed ID: 31807307
    [Abstract] [Full Text] [Related]

  • 20. Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure.
    Hoshikawa Y, Nikaki K, Sonmez S, Nakagawa K, Yazaki E, Sifrim D, Woodland P.
    Neurogastroenterol Motil; 2020 Jan 01; 32(1):e13735. PubMed ID: 31657519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.